Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Albumin-Bound Paclitaxel × Clear all

Sponsor

Conditions

Breast Neoplasms 49 Pancreatic Neoplasms 35 Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 18 Neoplasms 15 Lung Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Melanoma 6 Breast Neoplasms, Male 6 Urinary Bladder Neoplasms 5 Head and Neck Neoplasms 5 Carcinoma 5 Pancreatic Diseases 4 Inflammatory Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma 4 Stomach Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Esophageal Neoplasms 3 Endocrine System Diseases 3 Endocrine Gland Neoplasms 3 Digestive System Neoplasms 3 Digestive System Diseases 3 Carcinoma, Squamous Cell 3 Carcinoma, Pancreatic Ductal 3 Uveal Melanoma 2 Tongue Neoplasms 2

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡